Qingqing Zhang

Qingqing Zhang

Auto-generated profile, based on publicly available information

Qingqing Zhang

College of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, China; Hebei Higher Education Institute Applied Technology Research Center on TCM Development and Industrialization, Shijiazhuang 050091, China; International Joint Research Center on Resource Utilization and Quality Evaluation of Traditional Chinese Medicine of Hebei Province, Shijiazhuang 050091, China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2016 in Molecules
Verified
Journal Article
Open access
PDF file
ZZZhixin Zhang
Zhixin Zhang
LQLingling Qin
Lingling Qin
LPLong Peng
Long Peng
QZQingqing Zhang
Qingqing Zhang
QWQing Wang
Qing Wang
XGXiao Yan Gao
Xiao Yan Gao
Qingkailing injection (QKLI) is a modern Chinese medicine preparation derived from a well-known classical formulation, An-Gong-Niu-Huang Wan. Although the clinical efficacy of QKLI has been well defined, its severe adverse drug reactions (ADRs) were extensively increased. Through thorough attempts to reduce ADR rates, it was realized that the effect-based rational use plays the key role in clinical practices. Hence, the pharmacokinetic-pharmacodynamic (PK-PD) model was introduced in the present study, aiming to link the pharmacokinetic profiles with the therapeutic outcomes of QKLI, and subsequently to provide valuable guidelines for the rational use of QKLI in clinical settings. The PK properties of the six dominant ingredients in QKLI were compared between the normal treated group (NTG) and the pyrexia model group (MTG). Rectal temperatures were measured in parallel with blood sampling for NTG, MTG, model control group (MCG), and normal control group (NCG). Baicalin and geniposide exhibited appropriate PK parameters, and were selected as the PK markers to map the antipyretic effect of QKLI. Then, a PK-PD model was constructed upon the bacalin and geniposide plasma concentrations vs. the rectal temperature variation values, by a two-compartment PK model with a Sigmoid Emax PD model to explain the time delay between the drug plasma concentration of PK markers and the antipyretic effect after a single dose administration of QKLI. The findings obtained would provide fundamental information to propose a more reasonable dosage regimen and improve the level of individualized drug therapy in clinical settings.

14 July 2023 in Journal of Separation Science
Verified
Journal Article
Closed access
YFYuan Feng
Yuan Feng
YZYuguang Zheng
Yuguang Zheng
XXXiaodong Xin
Xiaodong Xin
QGQiuhong Guo
Qiuhong Guo
YHYing Hao
Ying Hao
QZQingqing Zhang
Qingqing Zhang

27 February 2024 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
YHYing Hao
Ying Hao
BWBingcheng Wang
Bingcheng Wang
YFYuan Feng
Yuan Feng
XXXiaodong Xin
Xiaodong Xin
YDYawei Deng
Yawei Deng
QZQingqing Zhang
Qingqing Zhang